Gamma-Tocotrienol Induces Apoptosis in Prostate Cancer Cells by Targeting the Ang-1/Tie-2 Signalling Pathway

Emerging evidence suggests that gamma-tocotrienol (γ-T3), a vitamin E isomer, has potent anti-cancer properties against a wide-range of cancers. γ-T3 not only inhibited the growth and survival of cancer cells in vitro, but also suppressed angiogenesis and tumour metastasis under in vivo conditions....

Full description

Saved in:
Bibliographic Details
Published inInternational journal of molecular sciences Vol. 20; no. 5; p. 1164
Main Authors Tang, Kai Dun, Liu, Ji, Russell, Pamela J, Clements, Judith A, Ling, Ming-Tat
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 07.03.2019
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Emerging evidence suggests that gamma-tocotrienol (γ-T3), a vitamin E isomer, has potent anti-cancer properties against a wide-range of cancers. γ-T3 not only inhibited the growth and survival of cancer cells in vitro, but also suppressed angiogenesis and tumour metastasis under in vivo conditions. Recently, γ-T3 was found to target cancer stem cells (CSCs), leading to suppression of tumour formation and chemosensitisation. Despite its promising anti-cancer potential, the exact mechanisms responsible for the effects of γ-T3 are still largely unknown. Here, we report the identification of Ang-1 (Angiopoietin-1)/Tie-2 as a novel γ-T3 downstream target. In prostate cancer cells, γ-T3 treatment leads to the suppression of Ang-1 at both the mRNA transcript and protein levels. Supplementing the cells with Ang-1 was found to protect them against the anti-CSC effect of γ-T3. Intriguingly, inactivation of Tie-2, a member receptor that mediates the effect of Ang-1, was found to significantly enhance the cytotoxic effect of γ-T3 through activation of AMP-activated protein kinase (AMPK) and subsequent interruption of autophagy. Our results highlighted the therapeutic potential of using γ-T3 in combination with a Tie-2 inhibitor to treat advanced prostate cancer.
AbstractList Emerging evidence suggests that gamma-tocotrienol (γ-T3), a vitamin E isomer, has potent anti-cancer properties against a wide-range of cancers. γ-T3 not only inhibited the growth and survival of cancer cells in vitro, but also suppressed angiogenesis and tumour metastasis under in vivo conditions. Recently, γ-T3 was found to target cancer stem cells (CSCs), leading to suppression of tumour formation and chemosensitisation. Despite its promising anti-cancer potential, the exact mechanisms responsible for the effects of γ-T3 are still largely unknown. Here, we report the identification of Ang-1 (Angiopoietin-1)/Tie-2 as a novel γ-T3 downstream target. In prostate cancer cells, γ-T3 treatment leads to the suppression of Ang-1 at both the mRNA transcript and protein levels. Supplementing the cells with Ang-1 was found to protect them against the anti-CSC effect of γ-T3. Intriguingly, inactivation of Tie-2, a member receptor that mediates the effect of Ang-1, was found to significantly enhance the cytotoxic effect of γ-T3 through activation of AMP-activated protein kinase (AMPK) and subsequent interruption of autophagy. Our results highlighted the therapeutic potential of using γ-T3 in combination with a Tie-2 inhibitor to treat advanced prostate cancer.
At this stage, chemotherapy and radiotherapy exhibit only limited benefits. [...]advanced prostate cancer remains incurable with current treatment strategies. [8], a tocotrienol-rich fraction (TRF) was able to inhibit the growth and induce apoptosis of human prostate cancer cell lines (LNCaP, DU145, PC-3), but not in normal human prostate epithelial cells, suggesting that it specifically targets cancer cells. NF-κB plays an important role in regulating cell survival through the induction of a series of anti-apoptotic proteins in cancer cells. [...]γ-T3-induced apoptosis was also found to be associated with the suppression of NF-κB, epidermal growth factor receptor (EGFR), and Id family proteins (Id1 and Id3) in prostate cancer [10]. To validate this finding, we first treated PC-3 cells with 10 µg/mL γ-T3 for 3 days under a serum-free condition [9]. γ-T3 not only significantly suppressed the mRNA level of Ang-1 in PC-3 cells, but also inhibited Ang-1 secretion from the cells (Figure 1A,B). Since Ang-1 has been shown to regulate prostate CSCs by functioning as an autocrine factor [18], we speculate that the anti-CSC function of T3 reported in our previous study may be due to the suppression of Ang-1 secretion.
Author Liu, Ji
Russell, Pamela J
Ling, Ming-Tat
Clements, Judith A
Tang, Kai Dun
AuthorAffiliation The School of Biomedical Sciences, Australian Prostate Cancer Research Centre-Queensland & Institute of Health and Biomedical Innovation, Queensland University of Technology and The Translational Research Institute, Queensland 4102, Australia; Ji.Liu@qimrberghofer.edu.au (J.L.); pamela.russell@qut.edu.au (P.J.R.); j.clements@qut.edu.au (J.A.C.)
AuthorAffiliation_xml – name: The School of Biomedical Sciences, Australian Prostate Cancer Research Centre-Queensland & Institute of Health and Biomedical Innovation, Queensland University of Technology and The Translational Research Institute, Queensland 4102, Australia; Ji.Liu@qimrberghofer.edu.au (J.L.); pamela.russell@qut.edu.au (P.J.R.); j.clements@qut.edu.au (J.A.C.)
Author_xml – sequence: 1
  givenname: Kai Dun
  surname: Tang
  fullname: Tang, Kai Dun
  email: kai.tang@qut.edu.au
  organization: The School of Biomedical Sciences, Australian Prostate Cancer Research Centre-Queensland & Institute of Health and Biomedical Innovation, Queensland University of Technology and The Translational Research Institute, Queensland 4102, Australia. kai.tang@qut.edu.au
– sequence: 2
  givenname: Ji
  surname: Liu
  fullname: Liu, Ji
  email: Ji.Liu@qimrberghofer.edu.au
  organization: The School of Biomedical Sciences, Australian Prostate Cancer Research Centre-Queensland & Institute of Health and Biomedical Innovation, Queensland University of Technology and The Translational Research Institute, Queensland 4102, Australia. Ji.Liu@qimrberghofer.edu.au
– sequence: 3
  givenname: Pamela J
  surname: Russell
  fullname: Russell, Pamela J
  email: pamela.russell@qut.edu.au
  organization: The School of Biomedical Sciences, Australian Prostate Cancer Research Centre-Queensland & Institute of Health and Biomedical Innovation, Queensland University of Technology and The Translational Research Institute, Queensland 4102, Australia. pamela.russell@qut.edu.au
– sequence: 4
  givenname: Judith A
  surname: Clements
  fullname: Clements, Judith A
  email: j.clements@qut.edu.au
  organization: The School of Biomedical Sciences, Australian Prostate Cancer Research Centre-Queensland & Institute of Health and Biomedical Innovation, Queensland University of Technology and The Translational Research Institute, Queensland 4102, Australia. j.clements@qut.edu.au
– sequence: 5
  givenname: Ming-Tat
  surname: Ling
  fullname: Ling, Ming-Tat
  email: mingtat.ling@qut.edu.au
  organization: The School of Biomedical Sciences, Australian Prostate Cancer Research Centre-Queensland & Institute of Health and Biomedical Innovation, Queensland University of Technology and The Translational Research Institute, Queensland 4102, Australia. mingtat.ling@qut.edu.au
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30866453$$D View this record in MEDLINE/PubMed
BookMark eNpdkk1vEzEQhi1URNvAjTOyxIUDS-2xvR8XpCiCEqkSlQhny-u1N4527WB7i_Lv2ZBSpZzGmnn0znjmvUYXPniD0FtKPjHWkBu3GxMQIigt-Qt0RTlAQUhZXZy9L9F1SjtCgIFoXqFLRuqy5IJdoeFWjaMqNkGHHJ3xYcBr303aJLzch30OySXsPL6PIWWVDV4pr03EKzMMCbcHvFGxN9n5HuetwUvfF_Rm40wB-IfrvRqGY-le5e1vdXiNXlo1JPPmMS7Qz69fNqtvxd332_VqeVdoXtW5sJTxtmo7a00trG47qBUA1MCJbZlqhIayaYVoqoaV2iroGJBaa0EbIKpibIHWJ90uqJ3cRzeqeJBBOfk3EWIvVcxOD0Zq6DjlvOZca265rW2pCWtVCw2hYm6wQJ9PWvupHU2njc9RDc9En1e828o-PMiSQ0MFmQU-PArE8GsyKcvRJT2vT3kTpiSBNpQJzsWx1_v_0F2Y4rzEmWIM4Hi2aqY-nig93yRFY5-GoUQeLSHPLTHj784_8AT_8wD7A6Kxsz4
CitedBy_id crossref_primary_10_3390_ijms24054923
crossref_primary_10_1186_s12906_023_04005_9
crossref_primary_10_3390_molecules27061896
crossref_primary_10_1002_biof_1873
crossref_primary_10_1016_j_prp_2023_154621
crossref_primary_10_1002_mc_23160
crossref_primary_10_1016_j_joim_2024_01_002
crossref_primary_10_3390_molecules25020398
crossref_primary_10_1016_j_jsbmb_2021_105835
crossref_primary_10_12688_f1000research_132031_1
crossref_primary_10_3389_fphar_2021_639628
crossref_primary_10_1002_ptr_8131
crossref_primary_10_1007_s40291_021_00538_2
crossref_primary_10_1016_j_advnut_2024_100240
crossref_primary_10_3389_fped_2021_667247
crossref_primary_10_3390_nu15010014
crossref_primary_10_3389_fcell_2022_820520
crossref_primary_10_1016_j_ijbiomac_2023_127162
crossref_primary_10_1016_j_semcancer_2019_06_011
crossref_primary_10_1016_j_heliyon_2023_e13684
crossref_primary_10_1158_1940_6207_CAPR_21_0508
crossref_primary_10_1016_j_oor_2023_100017
crossref_primary_10_3390_nu14204277
Cites_doi 10.1186/s12885-018-4462-y
10.1038/ncomms16106
10.1038/ncb2152
10.1158/1078-0432.CCR-06-0931
10.1271/bbb.67.1623
10.1016/j.freeradbiomed.2014.03.035
10.18632/oncotarget.6643
10.1016/j.juro.2007.03.135
10.1038/sj.bjc.6604763
10.1073/pnas.1100844108
10.1038/ncb2329
10.1016/j.bcp.2008.05.017
10.1093/carcin/bgs391
10.3389/fonc.2018.00248
10.5483/BMBRep.2018.51.2.233
10.1016/j.canlet.2009.10.012
10.1177/153537020422900806
10.1002/ijc.25546
10.1023/A:1006106209527
10.1038/cddis.2014.84
10.1093/carcin/bgr261
10.3177/jnsv.63.349
10.1002/biof.1259
10.1186/1472-6882-14-303
10.18632/oncotarget.3950
10.1111/j.1349-7006.2008.00961.x
10.1002/1097-0142(20010801)92:3<556::AID-CNCR1355>3.0.CO;2-Q
10.1016/j.lfs.2005.12.001
10.1038/bjc.2016.257
10.3390/ijms17101605
10.1016/j.freeradbiomed.2011.02.007
10.1159/000048262
10.1016/j.bbrc.2006.05.147
10.1177/1535370213511022
10.1038/84643
10.1054/bjoc.2001.1882
ContentType Journal Article
Copyright 2019. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2019 by the authors. 2019
Copyright_xml – notice: 2019. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2019 by the authors. 2019
DBID NPM
AAYXX
CITATION
3V.
7X7
7XB
88E
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
K9.
M0S
M1P
M2O
MBDVC
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOA
DOI 10.3390/ijms20051164
DatabaseName PubMed
CrossRef
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni Edition)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Research Library
Research Library (Corporate)
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Research Library
ProQuest Medical Library (Alumni)
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList PubMed
MEDLINE - Academic
Publicly Available Content Database

CrossRef

Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1422-0067
ExternalDocumentID oai_doaj_org_article_c2d4144844cc4f4f8f6c03bab2901579
10_3390_ijms20051164
30866453
Genre Journal Article
GroupedDBID ---
29J
2WC
3V.
53G
5GY
5VS
7X7
88E
8FE
8FG
8FH
8FI
8FJ
8G5
A8Z
AADQD
AAFWJ
AAHBH
ABDBF
ABJCF
ABUWG
ACGFO
ACIHN
ACIWK
ACPRK
ADBBV
AEAQA
AENEX
AFKRA
AFZYC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
CCPQU
CS3
D1I
DIK
DU5
DWQXO
E3Z
EBD
EBS
EJD
ESTFP
ESX
F5P
FRP
FYUFA
GNUQQ
GROUPED_DOAJ
GUQSH
GX1
HCIFZ
HH5
HMCUK
HYE
IAO
ITC
KB.
KQ8
LK8
M1P
M2O
M48
M7P
MODMG
M~E
NPM
O5R
O5S
OK1
P2P
PDBOC
PIMPY
PQQKQ
PROAC
PSQYO
RIG
RNS
RPM
TR2
TUS
UKHRP
~8M
AAYXX
CITATION
7XB
8FK
K9.
MBDVC
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
AFPKN
ID FETCH-LOGICAL-c478t-f134b7bdffe85fcbd28a2228240fb3a95c269b5597936cfa2d3208cc51920a733
IEDL.DBID RPM
ISSN 1422-0067
1661-6596
IngestDate Tue Oct 22 15:15:02 EDT 2024
Tue Sep 17 21:27:01 EDT 2024
Wed Dec 04 05:01:52 EST 2024
Thu Oct 10 22:14:51 EDT 2024
Fri Dec 06 01:06:00 EST 2024
Wed Oct 16 00:51:49 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords angiopoietin-1
prostate cancer
gamma-tocotrienol and autophagy
Tie-2
Language English
License https://creativecommons.org/licenses/by/4.0
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c478t-f134b7bdffe85fcbd28a2228240fb3a95c269b5597936cfa2d3208cc51920a733
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429150/
PMID 30866453
PQID 2332230867
PQPubID 2032341
ParticipantIDs doaj_primary_oai_doaj_org_article_c2d4144844cc4f4f8f6c03bab2901579
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6429150
proquest_miscellaneous_2191354459
proquest_journals_2332230867
crossref_primary_10_3390_ijms20051164
pubmed_primary_30866453
PublicationCentury 2000
PublicationDate 20190307
PublicationDateYYYYMMDD 2019-03-07
PublicationDate_xml – month: 3
  year: 2019
  text: 20190307
  day: 7
PublicationDecade 2010
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle International journal of molecular sciences
PublicationTitleAlternate Int J Mol Sci
PublicationYear 2019
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References ref13
ref35
ref12
ref34
ref15
ref37
ref36
Fukuhara (ref17) 2010; 25
ref31
ref30
ref11
ref33
ref10
ref32
ref2
ref1
Wan Nazaimoon (ref28) 2002; 24
ref39
ref16
ref38
Miyazawa (ref14) 2008; 17
ref19
ref18
Zhang (ref7) 2018; 40
ref24
ref23
ref26
ref25
ref20
ref22
ref21
ref27
ref29
ref8
ref9
ref4
ref3
ref6
ref5
ref40
References_xml – ident: ref6
  doi: 10.1186/s12885-018-4462-y
– ident: ref26
  doi: 10.1038/ncomms16106
– ident: ref35
  doi: 10.1038/ncb2152
– ident: ref3
  doi: 10.1158/1078-0432.CCR-06-0931
– ident: ref16
  doi: 10.1271/bbb.67.1623
– ident: ref29
  doi: 10.1016/j.freeradbiomed.2014.03.035
– ident: ref40
  doi: 10.18632/oncotarget.6643
– ident: ref1
  doi: 10.1016/j.juro.2007.03.135
– ident: ref10
  doi: 10.1038/sj.bjc.6604763
– ident: ref36
  doi: 10.1073/pnas.1100844108
– ident: ref34
  doi: 10.1038/ncb2329
– ident: ref15
  doi: 10.1016/j.bcp.2008.05.017
– ident: ref39
  doi: 10.1093/carcin/bgs391
– ident: ref19
  doi: 10.3389/fonc.2018.00248
– ident: ref20
  doi: 10.5483/BMBRep.2018.51.2.233
– ident: ref31
  doi: 10.1016/j.canlet.2009.10.012
– ident: ref12
  doi: 10.1177/153537020422900806
– ident: ref9
  doi: 10.1002/ijc.25546
– ident: ref2
  doi: 10.1023/A:1006106209527
– ident: ref38
  doi: 10.1038/cddis.2014.84
– ident: ref4
  doi: 10.1093/carcin/bgr261
– ident: ref5
  doi: 10.3177/jnsv.63.349
– ident: ref25
  doi: 10.1002/biof.1259
– volume: 40
  start-page: 999
  year: 2018
  ident: ref7
  article-title: gamma-tocotrienol inhibits the invasion and migration of human gastric cancer cells through downregulation of cyclooxygenase-2 expression
  publication-title: Oncol. Rep.
  contributor:
    fullname: Zhang
– ident: ref13
  doi: 10.1186/1472-6882-14-303
– ident: ref18
  doi: 10.18632/oncotarget.3950
– ident: ref27
  doi: 10.1111/j.1349-7006.2008.00961.x
– ident: ref24
  doi: 10.1002/1097-0142(20010801)92:3<556::AID-CNCR1355>3.0.CO;2-Q
– ident: ref30
  doi: 10.1016/j.lfs.2005.12.001
– ident: ref32
  doi: 10.1038/bjc.2016.257
– ident: ref33
  doi: 10.3390/ijms17101605
– ident: ref11
  doi: 10.1016/j.freeradbiomed.2011.02.007
– volume: 25
  start-page: 387
  year: 2010
  ident: ref17
  article-title: Angiopoietin-1/Tie2 receptor signaling in vascular quiescence and angiogenesis
  publication-title: Histol. Histopathol.
  contributor:
    fullname: Fukuhara
– ident: ref23
  doi: 10.1159/000048262
– ident: ref8
  doi: 10.1016/j.bbrc.2006.05.147
– volume: 24
  start-page: 77
  year: 2002
  ident: ref28
  article-title: Tocotrienols-rich diet decreases advanced glycosylation end-products in non-diabetic rats and improves glycemic control in streptozotocin-induced diabetic rats
  publication-title: Malays J. Pathol.
  contributor:
    fullname: Wan Nazaimoon
– ident: ref37
  doi: 10.1177/1535370213511022
– ident: ref21
  doi: 10.1038/84643
– volume: 17
  start-page: 253
  year: 2008
  ident: ref14
  article-title: Anti-angiogenic function of tocotrienol
  publication-title: Asia Pac. J. Clin. Nutr.
  contributor:
    fullname: Miyazawa
– ident: ref22
  doi: 10.1054/bjoc.2001.1882
SSID ssj0023259
Score 2.440866
Snippet Emerging evidence suggests that gamma-tocotrienol (γ-T3), a vitamin E isomer, has potent anti-cancer properties against a wide-range of cancers. γ-T3 not only...
At this stage, chemotherapy and radiotherapy exhibit only limited benefits. [...]advanced prostate cancer remains incurable with current treatment strategies....
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 1164
SubjectTerms Angiogenesis
angiopoietin-1
Apoptosis
Autocrine signalling
Autophagy
Cell growth
Chemotherapy
Cytotoxicity
Epidermal growth factor
Epidermal growth factor receptors
Epithelial cells
Experiments
gamma-tocotrienol and autophagy
Growth factors
Hypotheses
Kinases
mRNA
NF-κB protein
Phosphorylation
Prostate cancer
Protein expression
Proteins
Radiation therapy
Secretion
Signal transduction
Tie-2
Tumor cell lines
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Na9swFBejMNhl7Hvu2qHBdjSJ9WXpmIZ1ZYdRWAq9GUmWOo_EDnXKyH-_9ywnJGOwy66WbEvvWX6_n_Q-CPkomfLOmDoHPgsEJfIyt2xwsbLSaK2sStk-v6mrG_H1Vt4elPpCn7CUHjgJbuJZLQD0ayG8F1FEHZWfcmcdHgDKMoXuTdmOTI1UiwOqT27uHEj9pPm56nH7pCiUODJAQ57-v4HLP30kD4zO5TPydESLdJZG-Zw8Cu0L8jjVj9y-JMsvdrWy-aLzHdbFarslxVIcsPTpbN2tN13f9LRp6TWGdgCopHPU8T2dh-Wyp25LF4MfOFgvCjiQztq7vJgsmpAz-r25gzdjrDq9BpD4y25fkZvLz4v5VT6WT8i9KPUmjwUXrnR1jEHL6F3NtMX9HrDh0XFrpGfKOGQUhisfLas5m2rvAdOxqS05f01O2q4NbwkVwOoKFli0wQnGvDHSGnSasoUOdZQZ-bSTabVOWTIqYBco--pQ9hm5QIHv-2Bu6-ECaLwaNV79S-MZOdupqxoXXF8xDn8mDvyszMiHfTMsFTz_sG3oHqAPzIJj8iF4xJuk3f1I8FYlJM9IeaT3o6Eet7TNjyEdNzA4A7D69H_M7R15AojMDE5u5Rk52dw_hHNAPRv3fvjAfwM3XP-z
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Technology Collection
  dbid: 8FG
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lj9MwELZgERIXxJssCzISHK02fsU-oVLRXXFAK9GV9hbZTlyC2qQ0Xa3675lJ0rJFiGuchzNje75vPJ4h5IPiOnhrCwZ8FghKFBlzvAuxcsoao53us31-0xdX8uu1uh4cbu0QVrlfE7uFumgC-shHXMDQEwDAs0_rXwyrRuHu6lBC4z55kPJMY0ifmZ0fCJfgXbG0FGwQ08rqPvBdAM0fVT9XLTpU0lTLI5PUZe7_F9z8O2ryjhmaPSGPB_xIJ73Cn5J7Zf2MPOwrSu6ek-W5W60cmzehwUpZdbOkWJwDFgM6WTfrbdNWLa1qeomHPQBm0ilqfUOn5XLZUr-j8y4yHOwZBWRIJ_WCpaN5VTJOv1cL-DKeXqeXABtv3e4FuZp9mU8v2FBQgQWZmS2LqZA-80WMpVEx-IIbhx4gsOrRC2dV4Np65BhW6BAdLwQfmxAA5fGxy4R4SU7qpi5fEyqB56W85NGVXnIerFXOYhiVS01ZRJWQj3uZ5us-b0YOfANln9-VfUI-o8AP92C26-5Cs1nkw-TJAy8kED8jZQgyymiiDmPhncdNYJXZhJzt1ZUPU7DN_wyYhLw_NMPkwR0RV5fNDdwDfyEwHRG84lWv3UNP8FEtlUhIdqT3o64et9TVjy5BN3A6C0D79P_dekMeAfqyXUBbdkZOtpub8i0gnK1_1w3j3z9n-Vw
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1db9MwFL0aQ6C9IL4JDGQkeAxr_JHYDwiVijEhgSbRSnuLbMfugtKkNJ2g_57rpKlWGK-xkzg-du459vW9AG8ETa1RqohRz6JA8SyLNe1crLRQUqY67aN9fkvPZvzLhbg4gCHb6LYD2xulXcgnNVtV737_3HzACf8-KE6U7Cflj0UbFkcSpP634DZFmxicu77y3X4C0gaherf3f-44grsMeX3KBduzTV0I_5t459_uk9fs0el9uLclkmTcI_8ADlz9EO70qSU3j6D6rBcLHU8b24SUWXVTkZClA_8KZLxsluumLVtS1uQ8nPpAvkkmAf4VmbiqaonZkGnnIo6GjSBFJON6Hicn09LFlHwv5_jmcIydnCN__KU3j2F2-mk6OYu3mRViyzO5jn3CuMlM4b2TwltTUKnDUhCad2-YVsLSVJkgNhRLrde0YHQkrUW6R0c6Y-wJHNZN7Z4B4Sj4Euqo185wSq1SQqvgT6UT6QovIng79Gm-7ANo5Cg8Agz5dRgi-Bg6fFcnhL3uLjSreb6dRbmlBUcFKDm3lnvupU_tiBltwm6wyFQExwNc-TCUcsrwpxUgziJ4vSvGWRS2RnTtmiusg1_BQlwifMTTHt1dS4bREUG2h_teU_dL6vKyi9SN4k4h437-32e-gCNkYKpzasuO4XC9unIvkeWszatuAP8B4936BA
  priority: 102
  providerName: Scholars Portal
Title Gamma-Tocotrienol Induces Apoptosis in Prostate Cancer Cells by Targeting the Ang-1/Tie-2 Signalling Pathway
URI https://www.ncbi.nlm.nih.gov/pubmed/30866453
https://www.proquest.com/docview/2332230867
https://search.proquest.com/docview/2191354459
https://pubmed.ncbi.nlm.nih.gov/PMC6429150
https://doaj.org/article/c2d4144844cc4f4f8f6c03bab2901579
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBZtx0Zfyu5z1xkNtkc3sS629JiGpmXQErYU8mYk2co8fAlxysi_35EvoRl72osebNmWdSSd75M-HSH0hZPIaCnTAPgsEBRL40CRVmKluBQiUlEX7fM-un1g35Z8eYT4sBemFe0bnV9WRXlZ5T9bbeW6NKNBJzaa300BM0sAMqNjdAzud6DoPcuiAOg7hTsFPj_Kf5WNmzkJgRecohcUIHzEOD1wQ220_n9BzL-Vkk9cz-wlOusxI550ZXuFjrLqNXrenSK5e4OKG1WWKljUpnanY1V1gd2BHDAA4Mm6Xm_rJm9wXuG52-AB0BJPnaU3eJoVRYP1Di9aNTj4MAxoEE-qVRCOFnkWEPwjX8GX3Y51PAeo-Fvt3qKH2fViehv0hygEhsViG9iQMh3r1NpMcGt0SoRysz7gya2mSnJDIqkdr5A0MlaRlJKxMAaQHRmrmNJ36KSqq-wDwgy4XUgyYlWmGSFGSq6kk06pUGSp5R76OtRpsu5iZSTAMZwZkqdm8NCVq_B9Hhfhur1Qb1ZJb-fEkJQB2ROMGcMss8JGZky10m7hl8fSQxeDuZK-2zUJoTA-ORPHHvq8vw0dxq2CqCqrHyEP_AV1IYjgFe876-5LMrQOD8UHdj8o6uEdaKNtUO6-TZ7_95Mf0SmAMdnq2-ILdLLdPGafAPBstQ_NfBlDKmY3Pnp2dX0__-63kwe-c0Qc0jsm_LYb_AF6TQah
link.rule.ids 230,314,727,780,784,864,885,2102,2221,12056,12765,21388,24318,27924,27925,31719,31720,33373,33374,33744,33745,43310,43600,43805,53791,53793,73745,74035,74302
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lj9MwELagKwQXxHMpLGAkOFpt_Ep8Qt1qlwJLVUFW2ltkO3YJapPSdIX67xknadkixDXOw5mxPd83Hs8g9FZQaY1SOQE-CwTFs5ho2oRYaaGSRGrZZvucyskl_3QlrjqHW92FVe7WxGahzisbfOQDymDoMQDg8fvVTxKqRoXd1a6Exm10FDKnix46Oj2bzr7uKRejTbm0CKwQkULJNvSdAdEfFD-WdXCpRJHkB0apyd3_L8D5d9zkDUN0_gDd7xAkHrUqf4huufIRutPWlNw-RosPernUJK1sFWplldUCh_IcsBzg0apabaq6qHFR4lk47gFAE4-D3td47BaLGpstTpvYcLBoGLAhHpVzEg3SwhGKvxVz-HI4v45nABx_6e0TdHl-lo4npCupQCyPkw3xEeMmNrn3LhHempwmOviAwK57w7QSlkplAstQTFqvac7oMLEWcB4d6pixp6hXVqV7hjAHphdRR712hlNqlRJahUAqHSUu96KP3u1kmq3azBkZMI4g--ym7PvoNAh8f0_Id91cqNbzrJs-maU5B-qXcG4t99wnXtohM9qEbWARqz462akr6yZhnf0ZMn30Zt8M0yfsiejSVddwD_wFCwmJ4BXHrXb3PQmPSi5YH8UHej_o6mFLWXxvUnQDq1MAtZ__v1uv0d1J-uUiu_g4_fwC3QMspprwtvgE9Tbra_cS8M7GvOoG9W9QCv2t
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bb9MwFLagE2gviDuBAUaCR6uNb4mfUFdWxkVVBZ20t8h27BLUJl3TCfXfc5ykZUWI1zgXxz72-T778zkIvRVUWqNUToDPAkHxLCGaNhIrLVSaSi3baJ8TeX7BP1-Ky07_VHeyyt2c2EzUeWXDGnmfMjA9BgA86ftOFjH9MH6_uiIhg1TYae3SadxGR-AVB7SHjk7PJtNve_rFaJM6LQaPRKRQspXBMyD9_eLnsg7LK3Es-YGDauL4_wt8_q2hvOGUxvfRvQ5N4mHb_Q_QLVc-RHfa_JLbR2jxUS-XmswqW4W8WWW1wCFVB0wNeLiqVpuqLmpclHgajn4A6MSjYANrPHKLRY3NFs8anTh4Nww4EQ_LOYn7s8IRir8Xc_hyOMuOpwAif-ntY3QxPpuNzkmXXoFYnqQb4mPGTWJy710qvDU5TXVYDwIf7w3TSlgqlQmMQzFpvaY5o4PUWsB8dKATxp6gXlmV7hnCHFhfTB312hlOqVVKaBVEVTpOXe5FhN7t2jRbtVE0MmAfoe2zm20fodPQ4Pt7Quzr5kK1nmfdUMoszTnQwJRza7nnPvXSDpjRJmwJi0RF6GTXXVk3IOvsj_lE6M2-GIZS2B_Rpauu4R74CxaCE8Ernra9u69JeFRywSKUHPT7QVUPS8riRxOuGxieAtj9_P_Veo3ugj1nXz9NvrxAxwDLVKN0S05Qb7O-di8B-mzMq86mfwMeYwHp
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Gamma-Tocotrienol+Induces+Apoptosis+in+Prostate+Cancer+Cells+by+Targeting+the+Ang-1%2FTie-2+Signalling+Pathway&rft.jtitle=International+journal+of+molecular+sciences&rft.au=Tang%2C+Kai+Dun&rft.au=Liu%2C+Ji&rft.au=Russell%2C+Pamela+J&rft.au=Clements%2C+Judith+A&rft.date=2019-03-07&rft.eissn=1422-0067&rft.volume=20&rft.issue=5&rft_id=info:doi/10.3390%2Fijms20051164&rft_id=info%3Apmid%2F30866453&rft.externalDocID=30866453
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1422-0067&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1422-0067&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1422-0067&client=summon